Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cor Therapeutics Inc. (CORR) -- Ignore unavailable to you. Want to Upgrade?

To: Jerry Rush who wrote (238)	5/20/1998 2:29:00 PM
From: HerbertOtto	Respond to of 712

Looking for financial info on CORR. Market Guide says CORR has only about $70M in cash. Who will produce the new drug, Integrilin? If CORR, then has there been any talk of financing? Perhaps a Secondary Offering of stock? Or a Note Sale? GENZ just got a drug approval last week. Yesterday announced a private placement of $250M in convertible notes. 10% dilution potential. Stock dropped 10%. I would like to invest in CORR, but the finances are up in the air right now. Good luck, Herbert